ALLMedicine™ Chemotherapy-induced Oral Mucositis Center

Mar 17th, 2023 - Oral microbiota may be associated with serious local or systemic medical conditions resulting from chemotherapy. This study was conducted to evaluate the changes in the oral microbiota following the initiation of chemotherapy in patients with hema...

Mar 14th, 2023 - Approach Considerations Treatment of chemotherapy-induced oral mucositis begins with patient education and reinforcing the importance of good oral care throughout cancer treatment. Mucositis is self-limiting, and the goal of treatment is to make t...

Mar 14th, 2023 - Practice Essentials Oral mucositis is a common complication of cancer chemotherapy. It begins 5-10 days after the initiation of chemotherapy and lasts 7-14 days. Chemotherapy-induced oral mucositis causes the mucosal lining of the mouth to atrophy...

Mar 14th, 2023 - Approach Considerations Diagnosis is primarily based on the clinical findings and the chronology of the development of lesions. There are no routine hematologic or blood chemistry laboratory investigations needed in the workup of a patient with ch...

Mar 14th, 2023 - History Patients may initially describe generalized burning or sensitivity of the oral mucosa about 1 week after starting chemotherapy. With onset of frank ulcerations, patients typically report pain, which can be quite severe. Oral pain contribut...

Feb 24th, 2023 - This is a single-center randomized controlled trial . The goal of this study is to find whether topical benzydamine is superior in preventing chemotherapy-induced oral mucositis compared to standard methods, which include oral rinses with saline. ...

Jun 30th, 2022 - In patients with colorectal cancer, it is important to perform symptom management dynamically as well as specific treatments for cancer. It is extremely important for healthcare professionals to know the approaches that can be recommended to patie...

Nov 29th, 2021 - Febrile neutropenia (FN) is a clinically important adverse effect of myelosuppressive chemotherapy. If patients present with FN, attention is focussed on well-recognized sites of origin of infection: the airways, urinary tracts, and skin. However,...

Oct 25th, 2021 - Chemotherapy regimens not only improve the survival of patients with gastric cancer and colorectal cancer, but also cause obvious adverse reactions of digestive tract, such as chemotherapy-induced oral mucositis, abdominal pain, diarrhea, constipa...

Oct 15th, 2021 - Chemotherapy regimens not only improve the survival of patients with gastric cancer and colorectal cancer, but also cause obvious adverse reactions of digestive tract, such as chemotherapy-induced oral mucositis, abdominal pain, diarrhea, constipa...

Dec 5th, 2020 - Click here to view as PDF. PHASE III Second-Line Pemetrexed Does Not Provide Survival Advantage in Malignant Pleural Mesothelioma Pemetrexed seems to be one of the few therapies to exert positive effects in patients with malignant pleural mesot...

Sep 13th, 2016 - Oral cryotherapy, which is the cooling of the mouth with cold consumables, is effective for the prevention of oral mucositis in the setting of fluorouracil (FU)-based chemotherapy for solid cancers, say experts in a Clinical Evidence Synopsis publ...

Feb 3rd, 2015 - SAN ANTONIO – Low-level laser therapy proved highly effective in managing chemotherapy-induced oral mucositis in a retrospective study. Although this was the first study of low-level laser therapy in breast cancer patients, this form of therapy is.